Application, scope & purpose
The FDA's DHCoE plays a pivotal role in the oversight and advancement of digital health technologies, including Virtual Reality (VR) and Augmented Reality (AR) medical devices and digital therapeutics. Its primary purpose is to streamline the regulatory pathways for these innovative technologies, ensuring their safety, effectiveness, and quality for clinical applications. The scope covers a wide range of uses, from diagnosis and treatment to rehabilitation and disease management, across various medical specialties.
MV/VW environment
The DHCoE addresses medical applications within immersive environments. This includes the use of VR platforms for the treatment of anxiety disorders, Post-Traumatic Stress Disorder (PTSD), chronic pain management, and neurological rehabilitation.
It also encompasses AR applications for surgical planning, guidance, and training simulations. These technologies often utilize FDA-cleared or approved headsets and software platforms designed for specific medical indications.
Role of sandbox
The FDA's approach, particularly through the DHCoE, functions as a form of regulatory sandbox by providing a more agile and supportive environment for the development and review of novel digital health technologies.
While not a traditional 'sandbox' with explicit waivers, the DHCoE offers clear regulatory guidance, participates in pre-submission discussions, and facilitates expedited review pathways (e.g., through the De Novo classification process or 510(k) clearance) for AR/VR medical devices. This allows companies to test and refine their innovative solutions under the FDA's oversight before full market authorization, fostering innovation while maintaining rigorous safety and efficacy standards.
Results obtained
- Multiple VR medical devices received FDA clearance/approval.
- Established clear regulatory pathways for immersive medical technologies.
- Enhanced safety standards for AR/VR medical applications.
- Collaboration with Industry and Standards Bodies.
- UL 8400 safety standard adopted by OSHA for VR/AR equipment
References
- https://www.fda.gov/medical-devices/digital-health-center-excellence
- https://www.fda.gov/medical-devices/digital-health-center-excellence/augmented-reality-and-virtual-reality-medical-devices
- https://www.mofo.com/resources/insights/240830-immersive-technologies-the-uncertain-regulatory-landscape
- https://www.ul.com/insights/osha-adds-ul-8400-nrtl-programs-list-safety-standards
- https://incompliancemag.com/list-of-medical-devices-incorporating-virtual-reality-technology-updated/